Abstract : We report the case of a 77-year-old man who presented to our hospital with cecal cancer, lung metastasis, and liver metastasis in January 2013. After four courses of modified infusional intravenous fluorouracil and levofolinate with oxaliplatin (mFOLFOX 6) + bevacizumab, there was no new metastatic lesion and lung metastasis reduction was observed. Ileocecal resection was performed in May, left lower lung lobectomy in August, and extended right posterior segmentectomy + S8 partial liver resection was performed in December. The tumor marker declined initially ; thereafter, it gradually increased. Computed tomography (CT) performed in April 2014 revealed right inguinal mass around the mesh-plug prosthesis. A positron emission tomography-CT (PET-CT) also revealed a high 2-fluoro -2-deoxy -D-glucose (FDG) uptake at the same site. Right inguinal tumor resection was performed in July. Cancer tissues were confirmed by performing intraoperative rapid pathological diagnosis, and R0 resection could be achieved. Previous studies have reported malignant tumor metastases to the mesh -plug prosthesis, and this was believed to one of the sites that cancer cells can easily engraft. In particular, in patients with a history of advanced malignant tumors, if mass formation around the artifact insertion site is observed, the possibility of peritoneal metastasis should be considered.
INTRODUCTION
To our knowledge, there is currently no standard treatment for colorectal peritoneal dissemination, and its prognosis is poor. However, some reports show that there is a difference in prognosis depending on the seeding degree. Further, as per the Japanese Society for Cancer of the Colon and Rectum Guidelines 2016 for the treatment of colorectal cancer, "If it is possible to excise without excessive invasion, localized peritoneal dissemination should be resected" (1) .
We report a case of peritoneal metastasis from cecal cancer in inguinal hernioplasty scar. To the best of our knowledge, five studies have assessed peritoneal metastasis in inguinal hernioplasty scars, and the relationship between peritoneal chronic inflammation and implantation of cancer cells is stated as a hypothesis.
We could clinically diagnose peritoneal metastasis to a meshplug prosthesis, and complete resection of the tumor could be achieved. There has been no case with a complete resection of peritoneal metastasis to a mesh-plug prosthesis and long-term survival.
CASE PRESENTATION
In January 2013, a 77-year-old man presented to the department of gastroenterology at Aichi Cancer Center Hospital (Nagoya, Aichi Prefecture, Japan). A diagnosis of cecal carcinoma, liver metastasis (S5), and lung metastasis (left lung lower lobe, S10) was confirmed at a hospital that he previously visited. Although both metastatic lesions were considered resectable, the patient underwent neo-adjuvant chemotherapy according to his request. The specimen from the cecal tumor was found to be KRAS mutation type (G12x). After four courses of modified infusional intravenous fluorouracil and levofolinate with oxaliplatin (mFOLFOX 6) + bevacizumab, there was no new metastatic lesion, liver metastasis was reduced, and pulmonary metastasis decreased (Figures 1 A, B) .
At this time, he consented to undergo surgical resection. First, ileocecal dissection with regional node dissection (D3) was performed in May 2013. The pathological diagnosis was moderately differentiated adenocarcinomas [T4a/SE, tub 2, ly 2, v 2, inf β, N 1 (3/30)] (Figures 2 A, B) .
Imaging studies revealed that lung and liver metastases had increased and enlarged, respectively. Left lower lung lobectomy was performed in August in the same year, and three metastatic lesions were resected (Figure 3 A) . Furthermore, in December of the same year, extended right posterior segmentectomy + S8 partial liver resection was performed to excise three metastatic lesions (Figure 4 A) . Pathological findings showed tubular adenocarcinoma consistent with metastasis from cecal cancer (Figures 3 B,  4 B) . Thus, all the metastatic lesions were excised at once.
Tumor markers initially declined after hepatectomy ; however, they rapidly increased during May-June 2014 ( Figure 5 ).
In 
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Peritoneal cecal cancer metastasis to a mesh-plug prosthesis : A case report imaging. In July, the third laparotomy was performed. There was no other disseminated nodule. After cancer tissue was confirmed by intraoperative rapid pathological diagnosis, the tumor, including the meshplug prosthesis was completely excised (Figure 7 A) .
Pathological examination confirmed the presence of tubular adenocarcinoma and artificial fiber in the tissues. This was consistent with the diagnosis of colon cancer metastasis (Figure 7 B) .
Twelve courses of mFOLFOX6 comprised the adjuvant chemotherapy. Peritoneal and liver recurrences were detected in September 2015 ; these were treated with infusional intravenous fluorouracil and levofolinate with irinotecan (FOLFIRI) + bevacizumab. As of November 2017, tumor progression is being controlled.
DISCUSSION
Colorectal cancer has been reported to have a lower ability to adhere to and proliferate in the peritoneum than gastric cancer. Mochizuki et al. reported cytokines, such as TNFα, as a factor influencing the ability of peritoneal metastasis (2) .
Although the mechanism underlying the peritoneal metastasis to In the present case, the tumor was exposed to the peritoneum ; thereafter, multiple peritoneal metastases recurred. These processes may suggest that the floating cancer cells implanted and proliferated in the peritoneum of the mesh insertion site under the influence of the cytokine.
To the best of our knowledge, five studies have reported peritoneal metastasis in inguinal hernioplasty scar (3) (4) (5) (6) (7). Details of these five studies and those of our study are summarized in Table 1 . In three cases, the primary disease was colon cancer. In the other three cases, the primary diseases were gastric cancer, lymphoma, and pancreatic cancer. The anterior approach was used in three cases, and the laparoscopic approach was used in two cases. No causal relationship existed between the type of surgical approach used and peritoneal metastasis to a mesh-plug prosthesis.
Resection of peritoneal metastasis to a mesh-plug prosthesis was performed in two cases, including our case.
In the case reported by Imai et al., preoperative diagnosis was abscess and granulation of the plug part. The tumor was resected using the anterior approach and was diagnosed as peritoneal recurrence on pathological examination. He died 45 days after the surgery with surgical site recurrence and cancer peritonitis.
In our case, we considered the mass surrounding the mesh plug as peritoneal metastasis based on the preoperative image and the increase in the tumor marker, and tumorectomy was performed. Thus, a good field of view was obtained by laparotomy and complete resection could be achieved securing sufficient surgical margin.
In order to diagnose a mass formation around the mesh-plug prosthesis as peritoneal metastasis, a comprehensive judgment must be made, based on tumor enlargement, increase in the tumor markers, and PET-CT indications.
With respect to port-site metastasis, peritoneal metastasis to a mesh-plug prosthesis was detected on PET-CT with a high 2-fluoro-2-deoxy-D-glucose (FDG) uptake ; however, it is noteworthy that the abdominal mesh can show increased FDG uptake even in the absence of any pathology (4) .
Several studies have detected high FDG uptake in foreign body granulomas (FBG) using PET-CT. It is challenging to distinguish FBG from malignant metastases before surgery, and a confirmed diagnosis was established by performing tumor resection in most reported cases (8) .
Therefore, the optimal methods of metastasis diagnosis are tumorectomy or biopsy. In particular, for diseases, such as pancreatic cancer and lymphoma, the treatment policy changes according to the pathological diagnosis of the inguinal mass. Therefore, laparoscopic biopsy should be considered, as in the past report. In case of colon cancer metastasis, laparoscopic biopsy can be simultaneously preformed. However, in metachronous metastasis, laparoscopic examination may be difficult due to the adhesion ; thus, it is preferable to resect the tumor after the laparotomic biopsy, as in our case. For patients with peritoneal metastasis of colon cancer, long-term survival is possible with resection ; therefore, radical resection should be considered for solitary peritoneal metastasis to a mesh-plug prosthesis. In our case, R0 resection was achieved, and no recurrence was observed will 14 months after the surgery.
CONCLUSION
We report a case of a peritoneal cecal cancer metastasis to a mesh-plug prosthesis. The achievement of R0 resection in our case was remarkable.
If mass formation around the inguinal mesh-plug prosthesis is confirmed using imaging studies during the postoperative followup for advanced cancer, peritoneal metastasis should be suspected.
In solitary peritoneal metastasis to a mesh-plug prosthesis from colorectal cancer, long-term survival may be achieved using tumorectomy.
